Evidence map›Paper›PMID 31280407›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2019

Haloperidol Reduces the Activity of Complement and Induces the Anti-Inflammatory Transformation of Peritoneal Macrophages in Rats.

E G Cheremnykh, P A Ivanov, Oleg Yu Sokolov, T A Prokhorova, E B Tereshkina, N V Baymeeva, I I Miroshnichenko, N V Kost

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

E G CheremnykhMental Health Research Center, Moscow, Russia.
P A IvanovMental Health Research Center, Moscow, Russia.
Oleg Yu SokolovMental Health Research Center, Moscow, Russia. oleg-sokolov@yandex.ru.ORCID http://orcid.org/0000-0001-6993-8011
T A ProkhorovaMental Health Research Center, Moscow, Russia.
E B TereshkinaMental Health Research Center, Moscow, Russia.
N V BaymeevaMental Health Research Center, Moscow, Russia.
I I MiroshnichenkoMental Health Research Center, Moscow, Russia.
N V KostMental Health Research Center, Moscow, Russia.
Mental Health Research Center of Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that psychotropic substances affect the immune system. Unfortunately, chronic antipsychotic administration causes side toxicological effects, associated with oxidative stress. The mechanisms of these effects are still unclear. We investigated the impact of sub-chronic administration of haloperidol (Hal) on parameters of innate immunity and related systems in healthy rats and compared them with Hal content. Hal administration (0.5 mg/kg, 3 weeks) resulted in two-fold decrease of the activity of the complement system and hemostasis. Hal content correlated with the activity of the complement (r = -0.71), phagocytic activity of peritoneal macrophages (r = 0.78), leukocyte elastase (r = -0.71) and glutathione-S-transferase activity (r = -0.67). Hal fully blocked in vitro PMA-induced iNOS expression in macrophages and changed their morphology to "anti-inflammatory" phenotype. The comparison of in vivo and in vitro data showed that Hal has a direct effect on phagocytic component of innate immunity and an indirect effect on leukocyte elastase and antioxidant enzymes. The results obtained in the present study indicated that Hal significantly affects homeostasis and causes a number of complex biological transformations. Graphical Abstract.

Indexed as

AnimalsComplement ActivationGlutathioneGlutathione ReductaseGlutathione TransferaseHaloperidolHemostasisImmunity, InnateInflammationLeukocyte ElastaseMacrophages, PeritonealMaleNitric OxideNitric Oxide Synthase Type IIOxidation-ReductionPhagocytosisGlutathioneGlutathione ReductaseGlutathione TransferaseHaloperidolLeukocyte ElastaseNitric OxideNitric Oxide Synthase Type IINos2 protein, ratAntioxidant systemComplement systemHaloperidolHemostasisInnate immunityMacrophagesRats

Identifiers

PMID31280407
OpenAlexW2955098252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.